Cumberland Pharmaceuticals CPIX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's accounts payable?
- Cumberland Pharmaceuticals (CPIX) reported accounts payable of $16.54M in Q1 2026.
- How has Cumberland Pharmaceuticals's accounts payable changed year-over-year?
- Cumberland Pharmaceuticals's accounts payable increased by 18.7% year-over-year, from $13.93M to $16.54M.
- What is the long-term trend for Cumberland Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's accounts payable has grown at a 6.7% compound annual growth rate (CAGR), from $13.4M to $18.57M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.